The IPO pipeline just reopened in a big way. Not gradually. Not cautiously. All at once.

SpaceX filed its amended S-1 on June 1, set a fixed price of $135 per share, plans to sell 555.6 million shares, and is targeting a $75 billion raise at a $1.77 trillion valuation ahead of a June 12 Nasdaq debut under the ticker SPCX. If it prices as expected, it will be the largest IPO in U.S. history — more than triple the size of the 2014 Alibaba listing. Meanwhile, Quantinuum priced its own IPO at $60 per share on June 3, raising $1.68 billion — 60% above its original $1.05 billion target — and began trading on Nasdaq today under QNT. The book was reportedly 20x oversubscribed. Anthropic has also filed confidentially with the SEC. Goldman Sachs and Morgan Stanley are named as lead underwriters for that one too.

Goldman Sachs is the lead banker on the SpaceX offering. That is not a footnote. That is the whole story for GS investors right now.

The Macro Backdrop

Before getting into GS specifically, it helps to understand what kind of environment we are operating in. Goldman Sachs CEO David Solomon recently noted there is “plenty of liquidity” as major AI and technology firms move toward public markets. He also flagged — with some candor — that there is currently more greed than fear driving the rally. GS shares hit an all-time closing high of $1,064.58 on June 2, 2026, and the stock is up roughly 66% over the last 12 months. The 52-week range runs from $592.90 to $1,073.97. As of this morning, GS is trading near the upper end of that range and above its 200-day simple moving average — a structurally bullish configuration heading into one of the most active capital markets environments in years.

The broader financial sector is participating. M&A volumes at Goldman are on course to approach 2021 records according to GS President John Waldron. Risk appetite is elevated. And the IPO backlog — which spent the better part of two years largely frozen — is now clearing in volume.

GS Financials — What the Numbers Actually Show

Full-year 2025 revenue for Goldman Sachs came in at $59.40 billion, up 13.86% from $52.16 billion in 2024. Net earnings reached $16.24 billion, a 20.54% increase year over year. Diluted EPS for the first nine months of 2025 alone was $37.33, compared to $28.64 for the same period in 2024. Return on equity through Q3 2025 was running at 14.6% on a year-to-date basis, with book value per share at $353.79. The firm’s Global Banking and Markets segment — the one most directly tied to underwriting, advisory, and trading — is the engine here. Robust IPO activity feeds directly into that segment’s fee generation capacity.

Slight tangent worth noting: Goldman’s market cap grew from $179.76 billion in January 2025 to roughly $291.52 billion by late May 2026 — a 46%+ expansion in roughly 16 months. That is not just earnings growth. That is a market assigning significantly higher multiples to a firm it sees as structurally positioned to benefit from the next capital markets supercycle.

• 2025 Revenue: $59.40B (+13.86% YoY)
• 2025 Net Earnings: $16.24B (+20.54% YoY)
• Q3 2025 YTD EPS: $37.33 vs. $28.64 in 2024
• Annualized ROE (Q3 2025 YTD): 14.6%
• Book Value Per Share: $353.79
• GS 52-Week Range: $592.90 to $1,073.97
• GS All-Time High Close: $1,064.58 (June 2, 2026)
• 12-Month Price Appreciation: ~66%

The SpaceX and Quantinuum Effect on Fee Generation

Here is where it gets interesting for traders focused on GS specifically.

SpaceX plans to sell 555.6 million shares at $135. Underwriters — led by Goldman, followed by Morgan Stanley, Bank of America, Citigroup, and JPMorgan — also hold an option to purchase an additional 83.33 million shares at the IPO price, which adds roughly $11.2 billion of potential additional proceeds. At a $1.77 trillion valuation, SpaceX would be the seventh-largest U.S. company by market cap — above Tesla, which is currently valued near $1.6 trillion. SpaceX revenue reached $18.67 billion in 2025, up 33% year over year. The company carries a net loss of $4.94 billion for 2025, so this is a growth-at-scale, pre-profitability offering. But that has not dampened institutional demand at all.

Quantinuum tells a different kind of story. Revenue of just $30.9 million in 2025 — up 35% year over year — against a net loss of $192.6 million. R&D spend alone was $165.4 million, more than five times annual revenue. The IPO still priced above range, raised 60% more than targeted, and opened 20x oversubscribed. That is the market telling you it is willing to pay for optionality, not current earnings. The implied valuation of $14 to $15 billion on $30.9 million of revenue is speculative by any traditional measure. What it confirms, though, is that institutional capital is actively seeking hard-to-access technology exposure — and the banks running these deals collect fees regardless of where the stock trades after pricing.

Goldman is also reportedly co-leading underwriting on the anticipated Anthropic IPO. Three generational technology listings, one firm at the center of the fee structure. The revenue implications for GS’s Global Banking and Markets segment over the next two quarters are meaningful.

Sector Dynamics and Capital Rotation

Large asset managers are not waiting for these deals to price before positioning. Institutional flows into financial sector equities have accelerated in anticipation of underwriting fee generation — particularly into names with clear capital markets exposure. GS is the primary beneficiary. Morgan Stanley is a secondary one. JPMorgan participates but generates a larger share of revenue through consumer and commercial banking, which dilutes the IPO fee impact on a percentage basis.

The financial sector more broadly is seeing capital inflows as investors seek exposure to the investment banking cycle upturn. Goldman specifically outperformed peers like Citigroup and Wells Fargo on recent earnings, driven by strength in trading and investment banking. Its strategic positioning — leaning heavily into advisory, underwriting, and alternatives — is exactly the right configuration for this environment.

What matters is whether this IPO cycle sustains through Q3. If SpaceX opens clean and trades well in its first few weeks, the reflexive effect on deal flow appetite across the market could meaningfully accelerate the rest of the 2026 calendar. That is what institutional money appears to be pricing.

Technical Structure on GS

GS is trading near the top of its 52-week range and above its 200-day simple moving average. The all-time high close of $1,064.58 was set on June 2. The stock has gained roughly 6.5% over the past four weeks and approximately 66% over the trailing 12 months. That kind of momentum profile, with price extended above key moving averages, typically produces one of two outcomes: continuation on volume, or a reversion to test structure.

Key levels traders should be watching: the $1,040 to $1,050 zone represents near-term intraday support from the current session’s range. A decisive close above the $1,073.97 52-week high on meaningful volume would mark a technical breakout to all-time high territory with limited overhead resistance. On the downside, a pullback into the $960 to $975 range would represent approximately a 9-10% drawdown from highs — a zone where longer-term buyers have historically stepped in. The 50-day moving average sits below current price, providing a second layer of dynamic support. VWAP for active sessions has generally been tracking above the prior day close, which is consistent with institutional accumulation rather than distribution.

Volume is worth monitoring closely this week given the SpaceX roadshow kicking off and Quantinuum’s opening day. If GS volume runs notably above 30-day average on an up day, that is a signal that institutional positioning is active, not passive.

Three Scenarios Worth Building Around

Bull Case: SpaceX prices cleanly on June 11 and trades above the $135 IPO price in early sessions. Anthropic follows with a strong confidential filing that moves toward a public roadshow before year-end. GS Global Banking and Markets fee revenue surges in Q2 and Q3 2026. The stock pushes through $1,073.97 on volume and holds — establishing a new all-time high base. Analyst consensus price targets, currently averaging around $943 to $948, get revised meaningfully upward. GS potentially trades toward the $1,150 to $1,200 range as the capital markets cycle is revalued.

Base Case: SpaceX has a competent debut — prices at $135, opens modestly above, settles. Quantinuum stabilizes after its opening session. Goldman captures meaningful underwriting fees across both deals, Global Banking and Markets revenue grows sequentially in Q2 2026, and GS consolidates in the $980 to $1,060 range through mid-summer. M&A advisory volumes continue approaching 2021-level records without a sharp macro deterioration. Stock drifts toward consensus price targets over the next two quarters, with limited downside but also limited catalysts for a new leg higher until Anthropic pricing becomes visible.

Bear Case: SpaceX opens below $135 and trades poorly in the first two sessions — a meaningful signal that institutional demand at the $1.77 trillion valuation was front-loaded rather than durable. Retail participation disappoints. The broad IPO window closes faster than expected, particularly if macro conditions shift — rising Middle East tensions, renewed inflation concerns, or a Federal Reserve communication error on rate path. GS pulls back toward the $880 to $920 range, which would represent a 14-17% correction from current levels. Underwriting fee revenue for Q2 comes in below elevated expectations, and the stock underperforms the broader financial sector until Q3 data is available.

Active Trader Framework

A few things to hold onto as this week develops.

GS is extended. That is a fact, not a reason to avoid it — but it does change how you size and where you place risk. Traders chasing a stock at all-time highs in an elevated-volatility environment carry real gap risk in either direction. The SpaceX roadshow runs through June 11 with pricing expected that evening. GS is likely to remain in focus through that window. Watch how the stock responds to any noise around SpaceX demand — weak roadshow chatter could pressure GS intraday even without a change in fundamentals.

Positioning considerations: for traders looking for exposure to the capital markets cycle without directly holding GS at current levels, the XLF (Financial Select Sector ETF) and KBW Bank Index components offer diluted but lower-risk access. For those comfortable with GS directly, defined-risk structures using options around the SpaceX pricing date reduce the binary event exposure while preserving upside participation if the deal goes well.

Risk management is simple here: know your exit before you enter. A close below $1,020 on volume would be an early warning sign of deteriorating momentum. A close below $975 changes the short-term structure materially. Position size accordingly.

The IPO cycle opening this wide is genuinely rare. SpaceX at $1.77 trillion. Quantinuum at $15.6 billion on $30.9 million of revenue. Anthropic filing confidentially. Goldman Sachs at the center of all of it, with M&A volumes approaching 2021 records simultaneously. This is not a normal capital markets moment — and the market is reflecting that in GS’s stock price.

Whether it sustains depends on execution. The SpaceX debut on June 12 is the first real test. How that stock trades in its first 48 hours will tell you more about the durability of this cycle than any analyst note will.

Prepare accordingly.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.